一种强效趋化因子 CCR2b 受体拮抗剂(IC50 = 180 nM)。证明能有效抑制 MCP-1 诱导的细胞趋化(EC50 = 24 nM)。
Teijin compound 1 (CAS 226226-39-7) 参考文献
Moree et al (2004) Small molecule antagonists of the CCR2b receptor. Part 2: discovery process and initial structure-activity relationships of diamine derivatives. Bioorg.Med.Chem.Letts. 14 5413. Moree et al (2008) Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series. Bioorg.Med.Chem.Letts. 18 1869. Hall et al (2009) Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5. Mol.Pharmacol. 75 1325.